BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34670727)

  • 1. Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Monoistitutional Study.
    De Matteis S; Facondo G; Valeriani M; Vullo G; De Sanctis V; Ascolese AM; Campanella B; Scalabrino G; Osti MF
    Clin Breast Cancer; 2022 Apr; 22(3):e332-e340. PubMed ID: 34670727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer.
    Tovanabutra C; Katanyoo K; Uber P; Chomprasert K; Sukauichai S
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):119-125. PubMed ID: 31983173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two hypofractionated radiotherapy schedules in locally advanced postmastectomy breast cancer patients.
    Choudhary S; Gupta N; Misra S; Munnee NN; Kumar A; Ranjan R; Dhar SS; Kumar D; Mourya A; Aggarwal LM
    J Cancer Res Ther; 2020; 16(6):1331-1335. PubMed ID: 33342792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated Regional Nodal Irradiation for Women With Node-Positive Breast Cancer.
    Bellefqih S; Elmajjaoui S; Aarab J; Khalil J; Afif M; Lachgar A; El Kacemi H; Kebdani T; Benjaafar N
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):563-570. PubMed ID: 28126305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated radiotherapy in ten fractions for postmastectomy patients: a phase II study compared with another hypofractionation schedule with sixteen fractions.
    Jiang H; Meng L; Zhang H; Dai X; Zhang Q; Ju Z; Yu W; Ma L
    BMC Cancer; 2021 Dec; 21(1):1284. PubMed ID: 34852776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and toxicity following post-operative hypofractionated radiotherapy to the regional nodes and the breast or the chest wall in locally advanced breast cancer.
    Tramacere F; Arcangeli S; Colciago RR; Lucchini R; Pati F; Portaluri M
    Br J Radiol; 2022 Jul; 95(1135):20211299. PubMed ID: 35522785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative retrospective analysis of locoregional recurrence in unselected breast cancer patients treated with conventional versus hypofractionated radiotherapy at a tertiary cancer center?
    Yadav R; Lal P; Agarwal S; Misra S; Verma M; Das KJM; Senthil Kumar SK; Kumar A; Mishra SK; Agarwal A; Agarwal G; Mishra A; Chand G; Verma AK; Kumar S
    J Cancer Res Ther; 2020; 16(6):1314-1322. PubMed ID: 33342790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis.
    Dong J; Yang Y; Han D; Zhao Q; Liu C; Sun H; Wang Z; Lin H; Huang W
    Technol Cancer Res Treat; 2021; 20():15330338211064719. PubMed ID: 34898315
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypofractionated radiation treatment following mastectomy in early breast cancer: the Christchurch experience.
    Ko DH; Norriss A; Harrington CR; Robinson BA; James ML
    J Med Imaging Radiat Oncol; 2015 Apr; 59(2):243-7. PubMed ID: 25287654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Mono-Institutional Study: In Regard to De Matteis et al.
    Bölükbasi Y; Oymak E; Sezen D; Onal C
    Clin Breast Cancer; 2022 Jun; 22(4):e426-e427. PubMed ID: 34815173
    [No Abstract]   [Full Text] [Related]  

  • 11. Breast, chest wall, and nodal irradiation with prone set-up: Results of a hypofractionated trial with a median follow-up of 35 months.
    Shin SM; No HS; Vega RM; Fenton-Kerimian M; Maisonet O; Hitchen C; Keith DeWyngaert J; Formenti SC
    Pract Radiat Oncol; 2016; 6(4):e81-e88. PubMed ID: 26723552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extreme weekly locoregional hypofractionated radiation in elderly women with non-metastatic breast cancer.
    Rais F; Tsui JMG; Daianska A; Faye MD; Lambert C; David M; Panet-Raymond V; Azoulay M; Saidi A; Hijal T
    Radiother Oncol; 2021 Sep; 162():156-161. PubMed ID: 34273468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase 2 Study of 2 Weeks of Adjuvant Whole Breast/Chest Wall and/or Regional Nodal Radiation Therapy for Patients With Breast Cancer.
    Yadav BS; Sharma SC
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):874-881. PubMed ID: 29485066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From China.
    Wang SL; Fang H; Hu C; Song YW; Wang WH; Jin J; Liu YP; Ren H; Liu J; Li GF; Du XH; Tang Y; Jing H; Ma YC; Huang Z; Chen B; Tang Y; Li N; Lu NN; Qi SN; Yang Y; Sun GY; Liu XF; Li YX
    J Clin Oncol; 2020 Nov; 38(31):3604-3614. PubMed ID: 32780661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of toxicities and outcomes in patients with breast cancer treated with hypofractionated radiotherapy.
    Sindhu M; Malik M; Ahmed SF; Valiyaveettil D
    Indian J Cancer; 2020; 57(4):423-427. PubMed ID: 33078749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial.
    Khan AJ; Poppe MM; Goyal S; Kokeny KE; Kearney T; Kirstein L; Toppmeyer D; Moore DF; Chen C; Gaffney DK; Haffty BG
    J Clin Oncol; 2017 Jun; 35(18):2037-2043. PubMed ID: 28459606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials.
    Pfaffendorf C; Vonthein R; Krockenberger-Ziegler K; Dellas K; Schreiber A; Uhlemann D; Dinges S; Würschmidt F; Andreas P; Weinstrauch E; Eilf K; Rades D; Höller U; Combs SE; Kazmierczak R; Fehlauer F; Schreck U; Zimmer J; Dunst J; Krug D
    Breast; 2022 Aug; 64():136-142. PubMed ID: 35691249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated radiotherapy after breast-conserving surgery: Clinical and dosimetric factors predictive of acute skin toxicity.
    Ben Amor R; Bohli M; Naimi Z; Aissaoui D; Mejri N; Yahyaoui J; Hamdoun A; Kochbati L
    Strahlenther Onkol; 2023 Jan; 199(1):48-54. PubMed ID: 35943552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute skin toxicity of ultra-hypofractionated whole breast radiotherapy with simultaneous integrated boost for early breast cancer.
    Montero A; Ciérvide R; Cañadillas C; Álvarez B; García-Aranda M; Alonso R; López M; Chen-Zhao X; Alonso L; Valero J; Sánchez E; Hernando O; García de Acilu P; Fernandez-Letón P; Rubio C
    Clin Transl Radiat Oncol; 2023 Jul; 41():100651. PubMed ID: 37388711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.